External validation of the 2022 ACR/EULAR classification criteria in patients with suspected giant cell arteritis in a Dutch fast-track clinic

Benzer Materyaller

• Measuring treatment outcomes and change in disease activity in giant cell arteritis: a systematic literature review informing the development of the EULAR-ACR response criteria on behalf of the EULAR-ACR response criteria in giant cell arteritis task force
  Yazar:: Sofia Ramiro, ve diğerleri
  Baskı/Yayın Bilgisi: (2023-06-01)
• Performance of the modified 2022 ACR/EULAR giant cell arteritis classification criteria without age restriction for discriminating from Takayasu arteritis
  Yazar:: Takahiko Sugihara, ve diğerleri
  Baskı/Yayın Bilgisi: (2025-01-01)
• External validation of the 2022 ACR/EULAR classification criteria in patients with suspected giant cell arteritis in a Dutch fast-track clinic
  Yazar:: Elisabeth Brouwer, ve diğerleri
  Baskı/Yayın Bilgisi: (2023-08-01)
• What is new in imaging to assist in the diagnosis of giant cell arteritis and Takayasu’s arteritis since the EULAR and ACR/VF recommendations?
  Yazar:: Ruoning Ni, ve diğerleri
  Baskı/Yayın Bilgisi: (2024-10-01)
• Ultrasound halo count in the differential diagnosis of atherosclerosis and large vessel giant cell arteritis
  Yazar:: Irene Monjo-Henry, ve diğerleri
  Baskı/Yayın Bilgisi: (2023-02-01)